Cephalexin

Product NDC: 50090-4795
11-digit product format: 500904795
Labeler code: 50090
Product ID: 50090-4795_b0c558df-b03b-4d59-a6a2-d2d3310678ad
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cephalexin
Dosage form: FOR SUSPENSION
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA210221
Marketing category: ANDA
Marketing start: 2019-03-28
Substance: CEPHALEXIN
Active strength: 250 mg/5mL
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A210221-001	CEPHALEXIN	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2019-03-26
A210221-002	CEPHALEXIN	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2019-03-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A210221-001	AB
A210221-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A210221-001	CEPHALEXIN	EQ 125MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A210221-002	CEPHALEXIN	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2019-03-26	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A210221-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A210221-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A210221-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210221-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210221-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210221-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210221-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210221-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210221-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210221-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210221-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210221-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210221-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210221-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210221-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210221-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210221-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210221-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210221-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210221-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210221-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A210221-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210221-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210221-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210221-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210221-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210221-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210221-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210221-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A210221-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210221-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210221-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A210221-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A210221-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A210221-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A210221-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A210221-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A210221-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A210221-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A210221-002	AB	1	`bb7c543d1eb4…`

Additional Listing Data#

Finished product: Yes
Brand name base: Cephalexin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEPHALEXIN	250 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
OBN7UDS42Y	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
309113	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
28fec572-e3b9-448c-8626-5c0920f38eeb	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dfa3f520-409c-432e-b6d3-9250d468c772	Product name	1	20250401
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
64bb7f1a-2c2e-4741-8301-dbfeda7239f6	Product name	1	20190628
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717
398aa563-bb78-fe0f-46a8-757c40ef28bf	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50090-4795-0	2023-02-07	C162847	48780-1	f386c649-fac7-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use CEPHALEXIN FOR ORAL SUSPENSION safely and effectively. See full prescribing information for CEPHALEXIN FOR ORAL SUSPENSION CEPHALEXIN for oral suspension Initial U.S. Approval: 1971
50090-4795-0	2023-01-30	C162847	48780-1	f386c649-fac7-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use CEPHALEXIN FOR ORAL SUSPENSION safely and effectively. See full prescribing information for CEPHALEXIN FOR ORAL SUSPENSION CEPHALEXIN for oral suspension Initial U.S. Approval: 1971

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50090-4795-0	Cephalexin	200 mL in 1 BOTTLE	FOR SUSPENSION	200		5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-4795-0	ML - Milliliter	50090-4795	1300126a-63a9-47b9-ad3a-ae9e8869fa8e	1	2024-09-09

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-4795	CEPHALEXIN FOR SUSPENSION [A-S MEDICATION SOLUTIONS]	5	Current NDC, Legacy NDC, 1 package rows	20240731_28fec572-e3b9-448c-8626-5c0920f38eeb.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 20 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	06c2fb2e-0539-4f16-bac4-e15a575ca802	2026-04-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	Preferred Pharmaceuticlas Inc.	fbf5fcdf-40fc-40e5-b784-308032fff0e5	2026-03-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	Preferred Pharmaceuticals, Inc.	6c7bfa58-2d38-4607-8c33-485ba4931c68	2026-03-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	NuCare Pharmaceuticals,Inc.	ee278959-d321-d356-e053-2995a90a32c2	2026-01-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	c7028200-b141-496b-89e9-491558d4c879	2025-11-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	5f867aa3-ea64-4a14-a63b-979b8ff8d80c	2025-11-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	REMEDYREPACK INC.	9fc5cfb0-7ba0-4669-b79c-270b6a9ff573	2025-10-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	8d7f247a-3b42-4823-96fb-5f5c1bd94d49	2025-08-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	1bfa8744-24ee-4c70-845c-c532b8084433	2025-07-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	a8f14231-5d43-46f7-ba1f-d6de8162d5e7	2024-11-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	e186afb5-7531-45ea-b785-c230483a7747	2024-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	f1439d25-3d3d-4fe5-b6e7-d76e62892969	2024-08-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	A-S Medication Solutions	28fec572-e3b9-448c-8626-5c0920f38eeb	2024-07-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221 ndc (product): 50090-4795
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	df6bb893-e3d7-4c8f-8cec-35b4d2fa33b3	2024-07-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	f4ced8c7-a276-4a44-a60c-f8d1689a2bdf	2024-07-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	NuCare Pharmaceuticals,Inc.	ada33464-b416-9ac6-e053-2a95a90af787	2024-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	NuCare Pharmaceuticals,Inc.	90a76d24-e5a9-9000-e053-2a95a90ae8af	2024-06-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	92be9844-0775-4808-bdeb-dccb09647d91	2024-03-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	A-S Medication Solutions	0edeb103-5e94-4f42-828f-c7336486c784	2024-02-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221
Cephalexin	CEPHALEXIN	Ascend Laboratories, LLC	bb28751c-bd1b-4e7f-8271-a14c1b4314e3	2022-07-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210221 application number: ANDA210221

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
OBN7UDS42Y	CEPHALEXIN	23325-78-2	CEPHALEXIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309113	cephalexin 250 MG in 5 mL Oral Suspension	PSN	28fec572-e3b9-448c-8626-5c0920f38eeb	5
309113	cephalexin 50 MG/ML Oral Suspension	SCD	28fec572-e3b9-448c-8626-5c0920f38eeb	5
309113	cefalexin 50 MG/ML Oral Suspension	SY	28fec572-e3b9-448c-8626-5c0920f38eeb	5
309113	cephalexin 250 MG per 5 ML Oral Suspension	SY	28fec572-e3b9-448c-8626-5c0920f38eeb	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-4795-0	50090479500	200 mL in 1 BOTTLE (50090-4795-0)	200 ml	2019-12-12	0000-00-00	No	No	Current